For the Inventor, By the Inventor

Enter assignee name

Durham, NC, United States of America

Adherex Technologies, Inc.

USPTO Granted Patents = 31

Forward Citations = 298

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Orest W Blaschuk (29 out of 49 patents)

Barbara J Gour (26 out of 45 patents)

James Matthew Symonds (17 out of 17 patents)

4. Stephen Byers (8 out of 8 patents)

5. Stephanie Denise Michaud (4 out of 4 patents)

6. Patrick Doherty (3 out of 3 patents)

7. Feng Ni (2 out of 8 patents)

8. Zhigang Chen (2 out of 8 patents)

9. Thomas Spector (2 out of 14 patents)

10. Anmar Ali (2 out of 5 patents)

11. Zenjian Hu (2 out of 2 patents)

12. Donald W Kufe (1 out of 59 patents)

13. Shaomeng Wang (1 out of 77 patents)

14. William Paul Peters (1 out of 1 patent)

15. Brian Huber (1 out of 7 patents)

31 patents: Sort by Forward Citations

1. 8658618 - Methods for preventing or reducing neurotoxicity associated with administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs (2014-02-25),

2. 8318756 - Methods for administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs (2012-11-27),

3. 7481999 - Compounds and methods for modulating OB-cadherin-mediated function (2009-01-27),

4. 7476509 - Compounds and methods for modulating functions of nonclassical cadherins (2009-01-13),

5. 7456153 - Compounds and methods for modulating functions of classical cadherins (2008-11-25),

6. 7446120 - Peptidomimetic modulators of cell adhesion (2008-11-04),

7. 7268115 - Peptidomimetic modulators of cell adhesion (2007-09-11),

8. 7122623 - Compounds and methods for modulating cell adhesion (2006-10-17),

9. 6962969 - Compounds and methods for modulating nonclassical cadherin-mediated functions (2005-11-08),

10. 6830894 - Compounds and methods for modulating claudin-mediated functions (2004-12-14),

11. 6806255 - Compounds and methods for modulating adhesion molecule function (2004-10-19),

12. 6797807 - Compounds and methods for cancer therapy (2004-09-28),

13. 6756356 - Compounds and methods for modulating claudin-mediated functions (2004-06-29),

14. 6723700 - Compounds and methods for modulating claudin-mediated functions (2004-04-20),

15. 6706685 - Compounds and methods for stimulating &bgr;-catenin mediated gene expression and differentiation (2004-03-16),

Adherex Technologies, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative cancer therapeutics. With a commitment to improving patient outcomes, Adherex is dedicated to discovering new treatment options for various types of cancer. Through rigorous research and clinical trials, the company aims to bring effective and safe drugs to market that can make a significant impact on the lives of cancer patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

31 Patents

#33 in Durham, NC

#242 in North Carolina

#10,538 in US

#20,590 in the World

Durham, NC, United States of America

Adherex Technologies, Inc.

Forward Citations = 298

17 inventors:

Orest W Blaschuk (29 out of 49 patents)

Barbara J Gour (26 out of 45 patents)

James Matthew Symonds (17 out of 17 patents)

4. Stephen Byers (8 out of 8 patents)

5. Stephanie Denise Michaud (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…